Exact Mass: 576.0655332000001

Exact Mass Matches: 576.0655332000001

Found 22 metabolites which its exact mass value is equals to given mass value 576.0655332000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

2,6-di-O-Galloylarbutin

C26H24O15 (576.1115154)

Myricetin 3-(2,3,4-triacetylxyloside)

5,7-Dihydroxy-3-[(2,3,4-tri-O-acetyl-beta-D-xylopyranosyl)oxy]-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one

C26H24O15 (576.1115154)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent C1420 - Photosensitizing Agent D003879 - Dermatologic Agents

N-(4-chlorphenyl)-4-[[2,5-dichloro-4-[(dimethylamino) sulfonyl] phenyl]azo]-3-hydroxy-2-Naphthalenecarboxamide

C25H19Cl3N4O4S (576.0192544)

5,5-Dibromo-4,4-dinonyl-2,2-bi-1,3-thiazole

C24H38Br2N2S2 (576.0842988)

Titanyl phthalocyanine

C32H16N8OTi (576.0926476)

Benzothiazolium,3-pentyl-2-[3-(3-pentyl-2(3H)-benzothiazolylidene)-1-propen-1-yl]-, iodide(1:1)

C27H33IN2S2 (576.1129808000001)

Chlortetracycline bisulfate

C22H25ClN2O12S (576.081668)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

3-Mant-GDP

C18H22N6O12P2 (576.0770912)

A purine ribonucleoside 5-diphosphate that is GDP substituted at the 3 position by an N-methylanthraniloyl group.

[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl] [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate

C18H30N2O15P2 (576.1121370000001)

N-[[(4R,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide

C22H29BrN2O7S2 (576.0599464000001)

(2-chloro-4-{(Z)-[5-(2-chlorophenyl)-6-(ethoxycarbonyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene]methyl}-6-methoxyphenoxy)acetic acid

C26H22Cl2N2O7S (576.0524722)

N-[[(4R,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide

C22H29BrN2O7S2 (576.0599464000001)

2-[2,6-dichloro-4-[(E)-[6-ethoxycarbonyl-5-(3-methoxyphenyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2-ylidene]methyl]phenoxy]acetic acid

C26H22Cl2N2O7S (576.0524722)

2-[(3S,6aS,8R,10aS)-1-(4-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide

C24H27Cl3N2O6S (576.0655332000001)

2-Mant-GDP

C18H22N6O12P2 (576.0770912)

A purine ribonucleoside 5-diphosphate that is GDP substituted at position 2 by an N-methylanthraniloyl group.